{"id":554668,"date":"2021-07-27T13:48:01","date_gmt":"2021-07-27T13:48:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=554668"},"modified":"2021-07-27T13:48:01","modified_gmt":"2021-07-27T13:48:01","slug":"growth-drivers-of-blood-transfusion-market-2021-competitive-landscape-business-trends-and-effects-of-covid-19-analysis-top-vendors-grifols-sa-spain-immucor-inc-us-ortho-clinical-diagnos","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/growth-drivers-of-blood-transfusion-market-2021-competitive-landscape-business-trends-and-effects-of-covid-19-analysis-top-vendors-grifols-sa-spain-immucor-inc-us-ortho-clinical-diagnos_554668.html","title":{"rendered":"Growth Drivers of Blood Transfusion Market 2021 | Competitive Landscape, Business Trends and Effects of COVID 19 Analysis | Top Vendors: Grifols S.A. (Spain), Immucor Inc. (US), Ortho Clinical Diagnos"},"content":{"rendered":"
\"Growth<\/a><\/p>\n
\n
Blood Transfusion Market<\/div>\n<\/div>\n<\/div>\n
Global Blood Transfusion Market size, and focuses on the leading players in the market. Moreover, the report highlights the market size and CAGR\u00a0of the important segments, thus providing quick relevant information. This is often the foremost recent report, covering the present economic situation after the COVID-19 outbreak.<\/div>\n

Blood Transfusion Market Scenario:<\/strong><\/span><\/p>\n

Blood Transfusion Market <\/strong><\/a>is the method of transferring blood or blood products intravenously into circulation. Transfusions are done for various medical conditions such as anemia, sickle cell disease, a bleeding disorder such as hemophilia, or cancer where the blood components are lost to maintain blood levels and the blood components in the body. Thus, the blood transfusion market is predicted to grow with a CAGR of 5.6% during the forecast period.<\/strong><\/span><\/p>\n

Get a Sample Copy of this report with the latest Industry trends and COVID-19 Impact: https:\/\/straitsresearch.com\/report\/Blood Transfusion-Market\/request-sample<\/a><\/p>\n

<\/strong><\/strong><\/strong>The Major Players Covered in this Report: <\/em><\/strong>Grifols S.A. (Spain), Immucor Inc. (US), Ortho Clinical Diagnostics (US), Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), Hoffmann-La Roche Ltd. (Switzerland), Quotient Ltd. (Switzerland), BD (US), Terumo Corporation (Japan), Braun (Germany), & more…<\/em><\/strong><\/p>\n

According to the World Health Organization (WHO), cancer is the second leading cause of death, globally. It furthers stated that an estimated 9.6 million death i.e., 1 in 6 deaths were reported due to cancer in 2018. The American Cancer Society, on the other hand, estimated that more than 1.7 million new cancer cases were diagnosed in the U.S. in 2019. From the data by Cancer Research U.K., every year 367,000 new cases of cancer are reported in the U.K.<\/p>\n

Blood Transfusion Market: Segmentation:
<\/span><\/strong>By Product: <\/strong>Blood Bag and Accessory, Blood Mixer, Blood Component Separator, Apheresis Device, Pathogen Reduction System, Consumables, and Supplies, Others
By End-User: <\/strong>Hospitals, Blood Bank, Ambulatory Surgical Centers, Others<\/p>\n

Buy Full Report with Detail Analysis with COVID-19 Impact – https:\/\/straitsresearch.com\/buy-now\/blood-transfusion-market\/global\/<\/a><\/p>\n

<\/strong>Years that have been considered for the study of this report are as follows:<\/strong><\/p>\n